Cargando…
HIGH LONG-TERM DRUG-FREE REMISSION RATE FOR ACUTE VOGT–KOYANAGI–HARADA DISEASE WITH AN APPROPRIATE IMMUNOSUPPRESSIVE REGIMEN
PURPOSE: To report the clinical profile and outcomes of acute Vogt–Koyanagi–Harada disease with a strict immunosuppression regimen and investigate the risk factors for a prolonged disease course. METHODS: A total of 101 patients with acute Vogt–Koyanagi–Harada (202 eyes) with more than 24 months of...
Autores principales: | Wang, Kaixuan, Zheng, Chuanzhen, Zhao, Guixia, Zhang, Mi, Liu, Tong, Li, Huan, Tao, Qingqin, Cheng, Zhaohui, Li, Xiaorong, Zhang, Xiaomin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Retina
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442124/ https://www.ncbi.nlm.nih.gov/pubmed/37224445 http://dx.doi.org/10.1097/IAE.0000000000003837 |
Ejemplares similares
-
Outcomes of retinal pigment epithelial detachment in Vogt-Koyanagi-Harada disease: a longitudinal analysis
por: Zheng, Chuanzhen, et al.
Publicado: (2022) -
Successive onset of Vogt-Koyanagi-Harada syndrome in father and son
por: Li, Hougang, et al.
Publicado: (2023) -
Treatment of Vogt-Koyanagi-Harada Disease
por: Alaql, Musab K, et al.
Publicado: (2020) -
Tofacitinib in Vogt-Koyanagi-Harada disease
por: Dutta Majumder, Parthopratim, et al.
Publicado: (2020) -
An Unusual Presentation of Vogt–Koyanagi–Harada
por: Ipek, Sefik Can, et al.
Publicado: (2021)